HTDS to release its next 90 to 180 day forward guidance report

HTDS www.htdsmedical.com - The Company intends to release its next 90 to 180 day forward guidance concurrent with its profile launch on www.stockprofile.com .

The guidance report will cover further outstanding topics namely OTCBB up listing status, audit, forward stock split, vote, Pink Sheets (skull and bones) rank, stock chill, MindUp cancer project and split off together with other corporate matters. The report is quite comprehensive and should provide the issuer's followers with a clear road map as to where the company intends to get to and what it intends to accomplish in the next 90 to 180 days. More importantly the company will be meeting early next week with the principal representatives of the Canadian Pharmaceutical company in Belgrade Serbia in regards to the Slavica Bio Chem's MindUp cancer project and its planned split off. The company feels that this is a significant event that its followers should be made aware of.

StockProfile.com provides the investing public with a free unique information portal for investors who like to conduct their own research and make their own investment decisions. The platform allows users to review and investigate dynamic publicly traded companies in a user-friendly environment.

If you are interested in viewing HTDS profile, please visit www.StockProfile.com.

To be included in HTDS' e-mail database for press releases and industry updates, please subscribe at or opt in with your email address at this link http://www.minamargroup.com/updates/.